These drugs belong to a class known as glucagon-like peptide receptor agonists (GLP-1RAs), which mimic a natural hormone that helps regulate blood sugar and appetite
Revenue from operations rose 39.8 per cent to nearly Rs 3,818 crore, while expenses jumped 41.3 per cent due to an increase in the costs of raw materials
